Nolatrexed

CAS No. 147149-76-6

Nolatrexed( —— )

Catalog No. M17316 CAS No. 147149-76-6

Nolatrexed is a thymidylate synthase inhibitor with potential anticancer activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 41 Get Quote
5MG 75 Get Quote
10MG 136 Get Quote
25MG 227 Get Quote
50MG 408 Get Quote
100MG 600 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Nolatrexed
  • Note
    Research use only, not for human use.
  • Brief Description
    Nolatrexed is a thymidylate synthase inhibitor with potential anticancer activity.
  • Description
    Nolatrexed is a thymidylate synthase inhibitor with potential anticancer activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Lipase
  • Recptor
    Thymidylate synthase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    147149-76-6
  • Formula Weight
    284.33
  • Molecular Formula
    C14H12N4OS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc1c(c2c(cc1)[nH]c(nc2=O)N)Sc1ccncc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1: Zheng J, et al. Metastatic nasopharyngeal carcinoma outcomes in patients on cisplatin with nolatrexed or 5-fluorouracil. Oncol Res Treat. 2014;37(10):540-4. doi: 10.1159/000368107. Epub 2014 Sep 16. PubMed PMID: 25342504.
molnova catalog
related products
  • Atglistatin

    Atglistatin is a highly potent, selective and competitive inhibitor of adipose triglyceride lipase (ATGL) with an?IC50?of ~0.7 μM for inhibition of lipolysis in vitro, but no toxicity up to a concentration of 50 μM.

  • Cravatt Reagent

    Cravatt Reagent is a potent and selective MAGL inhibitor. Cravatt Reagent inhibits MAGL (IC50 = 9.1 nM). MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model.

  • Lalistat 2

    Lalistat 2 is a selective inhibitor of lysosomal acid lipase with IC50 of 152 nM and exhibits no inhibition of human pancreatic lipase or bovine milk lipoprotein lipase (up to 10 μM).